Biomedical Development Corporation
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1984-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.biodevcorp.com/
Clinical Trials
11
Active:1
Completed:8
Trial Phases
3 Phases
Phase 1:4
Phase 2:3
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (50.0%)Phase 2
3 (37.5%)Not Applicable
1 (12.5%)Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder
Not Applicable
Active, not recruiting
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2023-12-18
- Lead Sponsor
- Biomedical Development Corporation
- Target Recruit Count
- 25
- Registration Number
- NCT05859035
- Locations
- 🇺🇸
UT Health San Antonio, San Antonio, Texas, United States
mHealth for Patient Self-Management of Opioid Use Disorder
Completed
- Conditions
- Opioid-use Disorder
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Biomedical Development Corporation
- Target Recruit Count
- 19
- Registration Number
- NCT03633929
- Locations
- 🇺🇸
Biomedical Development Corporation, San Antonio, Texas, United States
🇺🇸Community Medical Services, San Antonio, Texas, United States
Efficacy of Iocide Oral Rinse Against Gingival Inflammation
Phase 2
- Conditions
- GingivitisInvestigation of Biological Markers of Inflammation
- Interventions
- Drug: Iocide Oral RinseDrug: Placebo
- First Posted Date
- 2013-02-01
- Last Posted Date
- 2013-08-14
- Lead Sponsor
- Biomedical Development Corporation
- Target Recruit Count
- 76
- Registration Number
- NCT01782170
- Locations
- 🇺🇸
University of Kentucky, Center for Oral Health Research, College of Dentistry, Lexington, Kentucky, United States
Relationship Between Vestibular Function and Topographic Memory
- Conditions
- Normal Elderly Population
- First Posted Date
- 2013-01-31
- Last Posted Date
- 2013-02-01
- Lead Sponsor
- Biomedical Development Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT01780896
- Locations
- 🇺🇸
Ears of Texas, PA, San Antonio, Texas, United States
🇺🇸Michael Roman, PhD, LSSP, San Antonio, Texas, United States
Dose-Response Study of Iocide Oral Rinse
Phase 2
Completed
- Conditions
- Gingivitis
- Interventions
- Drug: Iocide Oral RinseDrug: Placebo
- First Posted Date
- 2010-04-14
- Last Posted Date
- 2013-01-29
- Lead Sponsor
- Biomedical Development Corporation
- Target Recruit Count
- 97
- Registration Number
- NCT01103102
- Locations
- 🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found